SARS-CoV-2 infection of human iPSC-derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19.
Juan A Perez-Bermejo, Serah Kang, Sarah J Rockwood, Camille R Simoneau, David A Joy, Ana C Silva, Gokul N Ramadoss, Will R Flanigan, Parinaz Fozouni, Huihui Li, Pei-Yi Chen, Ken Nakamura, Jeffrey D Whitman, Paul J Hanson, Bruce M McManus, Melanie Ott, Bruce R Conklin, Todd C McDevitt
Author Information
Juan A Perez-Bermejo: Gladstone Institutes, San Francisco, CA 94158, USA. ORCID
Serah Kang: Gladstone Institutes, San Francisco, CA 94158, USA. ORCID
Sarah J Rockwood: Gladstone Institutes, San Francisco, CA 94158, USA. ORCID
Camille R Simoneau: Gladstone Institutes, San Francisco, CA 94158, USA. ORCID
David A Joy: Gladstone Institutes, San Francisco, CA 94158, USA. ORCID
Ana C Silva: Gladstone Institutes, San Francisco, CA 94158, USA.
Gokul N Ramadoss: Gladstone Institutes, San Francisco, CA 94158, USA. ORCID
Will R Flanigan: Gladstone Institutes, San Francisco, CA 94158, USA. ORCID
Parinaz Fozouni: Gladstone Institutes, San Francisco, CA 94158, USA. ORCID
Huihui Li: Gladstone Institutes, San Francisco, CA 94158, USA. ORCID
Pei-Yi Chen: Gladstone Institutes, San Francisco, CA 94158, USA. ORCID
Ken Nakamura: Gladstone Institutes, San Francisco, CA 94158, USA. ORCID
Jeffrey D Whitman: Department of Laboratory Medicine, UCSF, San Francisco, CA 94143, USA. ORCID
Paul J Hanson: Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6Z 1Y6, Canada. ORCID
Bruce M McManus: Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6Z 1Y6, Canada.
Melanie Ott: Gladstone Institutes, San Francisco, CA 94158, USA. todd.mcdevitt@gladstone.ucsf.edu bconklin@gladstone.ucsf.edu melanie.ott@gladstone.ucsf.edu. ORCID
Bruce R Conklin: Gladstone Institutes, San Francisco, CA 94158, USA. todd.mcdevitt@gladstone.ucsf.edu bconklin@gladstone.ucsf.edu melanie.ott@gladstone.ucsf.edu. ORCID
Todd C McDevitt: Gladstone Institutes, San Francisco, CA 94158, USA. todd.mcdevitt@gladstone.ucsf.edu bconklin@gladstone.ucsf.edu melanie.ott@gladstone.ucsf.edu. ORCID
Although coronavirus disease 2019 (COVID-19) causes cardiac dysfunction in up to 25% of patients, its pathogenesis remains unclear. Exposure of human induced pluripotent stem cell (iPSC)-derived heart cells to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) revealed productive infection and robust transcriptomic and morphological signatures of damage, particularly in cardiomyocytes. Transcriptomic disruption of structural genes corroborates adverse morphologic features, which included a distinct pattern of myofibrillar fragmentation and nuclear disruption. Human autopsy specimens from patients with COVID-19 reflected similar alterations, particularly sarcomeric fragmentation. These notable cytopathic features in cardiomyocytes provide insights into SARS-CoV-2-induced cardiac damage, offer a platform for discovery of potential therapeutics, and raise concerns about the long-term consequences of COVID-19 in asymptomatic and severe cases.
References
Cell. 2020 Dec 10;183(6):1520-1535.e14
[PMID: 33157038]
JAMA Cardiol. 2020 Nov 01;5(11):1265-1273
[PMID: 32730619]
Eur Heart J. 2020 May 14;41(19):1804-1806
[PMID: 32293672]